Who is sponsoring NCT05324033?

NCT05324033 is sponsored by Helwan University.

What condition does NCT05324033 study?

NCT05324033 studies Cancer, Bladder.

What drugs are being tested in NCT05324033?

Interventions: multiparametric MRI on the bladder, diagnostic cystoscopy +/- TURBT.

What is the status of NCT05324033?

NCT05324033 is currently COMPLETED.

Last reviewed 2023-04-04 · How we verify

Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

NCT05324033 COMPLETED

Differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is a cornerstone in the treatment plans.Therefore, this study will try to evaluate the sensitivity and reliability of mpMRI in accurate diagnosis of cancer bladder. Primary objective: to detect the sensitivity of multiparametric MRI in differentiation between muscle Invasive and non-muscle invasive Urinary Bladder Cancer in relation to the conventional cystoscopy and histopathological examination of the biopsy.

Details

Lead sponsor	Helwan University
Status	COMPLETED
Enrolment	30
Start date	Sun May 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Apr 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Cancer, Bladder

Interventions

multiparametric MRI on the bladder
diagnostic cystoscopy +/- TURBT

Countries

Egypt